Nabla Bio

AI to design antibodies for intractable diseases.

About

Founded

2020

Headquarters

Boston, Massachusetts

Industry

Biotech, Artificial Intelligence (AI)

Company Description

The next-generation of antibodies will be designed, not discovered.

Quick Links

WebsiteJobs

Funding

Total Raised

$11.3 million

Valuation

Undisclosed

Significant Investors

Y Combinator, Fifty Years, Cantos Ventures, Khosla Ventures, Zetta Venture Partners

Company Traction

  • As of December 2021, Nabla Bio can express thousands or a million antibodies in a single tube.

Leadership Team

  • Surge Biswas: Co-Founder & CEO of Nabla Bio. Former Scientist at Phil Wigge Lab.

People also viewed